A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers

Clinical trial NCT07722871 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07722871
Sponsor: Addpharma Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2026-07-01
Primary completion: 2026-10-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.